journal article·2024-05Open access

Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke Therapy

Ya Zhao, Qian Li, Jingyan Niu, Erliang Guo, Chenchen Zhao, Jian Zhang, Xue Liu, Lihua Wang, Lang Rao, Xiaoyuan Chen, Kuikun Yang

Advanced Materials· Volume 36· Issue 21

Abstract

Abstract Neuroinflammation has emerged as a major concern in ischemic stroke therapy because it exacebates neurological dysfunction and suppresses neurological recovery after ischemia/reperfusion. Fingolimod hydrochloride (FTY720) is an FDA‐approved anti‐inflammatory drug which exhibits potential neuroprotective effects in ischemic brain parenchyma. However, delivering a sufficient amount of FTY720 through the blood–brain barrier into brain lesions without inducing severe cardiovascular side effects remains challenging. Here, a neutrophil membrane‐camouflaged polyprodrug nanomedicine that can migrate into ischemic brain tissues and in situ release FTY720 in response to elevated levels of reactive oxygen species. This nanomedicine delivers 15.2‐fold more FTY720 into the ischemic brain and significantly reduces the risk of cardiotoxicity and infection compared with intravenously administered free drug. In addition, single‐cell RNA‐sequencing analysis identifies that the nanomedicine attenuates poststroke inflammation by reprogramming microglia toward anti‐inflammatory phenotypes, which is realized via modulating Cebpb‐regulated activation of NLRP3 inflammasomes and secretion of CXCL2 chemokine. This study offers new insights into the design and fabrication of polyprodrug nanomedicines for effective suppression of inflammation in ischemic stroke therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neuroinflammation and Neurodegeneration Mechanisms · Sphingolipid Metabolism and Signaling · Inflammasome and immune disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Life Science and Technology Harbin Institute of Technology Harbin Heilongjiang 150080 P. R. China

Department of Neurology The Second Affiliated Hospital of Harbin Medical University Harbin Heilongjiang 150081 P. R. China

Department of Thoracic Surgery Harbin Medical University Cancer Hospital Harbin Heilongjiang 150081 P. R. China

Institute of Biomedical Health Technology and Engineering Shenzhen Bay Laboratory Shenzhen Guangdong 518132 P. R. China

Biofunctional Experiment Teaching Center Harbin Medical University Harbin Heilongjiang 150081 P. R. China

Department of Pharmacology Harbin Medical University Harbin Heilongjiang 150081 P. R. China

Departments of Diagnostic Radiology Surgery, Chemical and Biomolecular Engineering and Biomedical Engineering Yong Loo Lin School of Medicine and College of Design and Engineering National University of Singapore Singapore 119074 Singapore

Clinical Imaging Research Centre Centre for Translational Medicine Yong Loo Lin School of Medicine National University of Singapore Singapore 117599 Singapore

Nanomedicine Translational Research Program NUS Center for Nanomedicine Yong Loo Lin School of Medicine National University of Singapore Singapore 117597 Singapore

Institute of Molecular and Cell Biology Agency for Science Technology and Research (A*STAR) 61 Biopolis Drive, Proteos Singapore 138673 Singapore

Funding

National Natural Science Foundation of China · Natural Science Foundation of Heilongjiang Province · National University of Singapore

References (66)

Show source-provided references
1. 10.1161/CIR.000000000000112310.1161/CIR.0000000000001123 ↗
2. 10.1016/S1474-4422(21)00252-010.1016/S1474-4422(21)00252-0 ↗
3. 10.1038/nrn110610.1038/nrn1106 ↗
4. 10.1016/j.neuron.2010.07.00210.1016/j.neuron.2010.07.002 ↗
5. 10.1161/01.STR.0000143219.16695.af10.1161/01.STR.0000143219.16695.af ↗
6. 10.1016/j.tins.2008.09.00610.1016/j.tins.2008.09.006 ↗
7. 10.1378/chest.08-072010.1378/chest.08-0720 ↗
8. 10.5853/jos.2016.0151510.5853/jos.2016.01515 ↗
9. 10.1038/nm.250710.1038/nm.2507 ↗
10. 10.1038/nm.239910.1038/nm.2399 ↗
11. 10.1016/j.pneurobio.2016.05.00110.1016/j.pneurobio.2016.05.001 ↗
12. 10.1007/s12264-019-00388-310.1007/s12264-019-00388-3 ↗
13. 10.3389/fimmu.2020.0000110.3389/fimmu.2020.00001 ↗
14. 10.1038/jcbfm.2012.8810.1038/jcbfm.2012.88 ↗
15. 10.1097/00004647-200101000-0000210.1097/00004647-200101000-00002 ↗
16. Jiang C. T. · Mol. Med. Rep. · 2020 · 21 · 2006
17. 10.1038/aps.2016.16210.1038/aps.2016.162 ↗
18. 10.1016/j.biopha.2018.05.14310.1016/j.biopha.2018.05.143 ↗
19. 10.1038/nrd324810.1038/nrd3248 ↗
20. 10.1111/j.1476-5381.2009.00451.x10.1111/j.1476-5381.2009.00451.x ↗
21. 10.1002/brb3.217910.1002/brb3.2179 ↗
22. 10.1016/j.brainres.2019.14650910.1016/j.brainres.2019.146509 ↗
23. 10.3389/fimmu.2018.0169610.3389/fimmu.2018.01696 ↗
24. 10.1161/STROKEAHA.122.03993210.1161/STROKEAHA.122.039932 ↗
25. 10.1016/j.ahj.2014.06.02810.1016/j.ahj.2014.06.028 ↗
26. 10.1177/135245851558775310.1177/1352458515587753 ↗
27. 10.1177/117957351984994510.1177/1179573519849945 ↗
28. 10.1177/135245851880708810.1177/1352458518807088 ↗
29. 10.1007/s13760-017-0794-710.1007/s13760-017-0794-7 ↗
30. 10.1007/s12325-011-0004-610.1007/s12325-011-0004-6 ↗
31. 10.1016/j.lfs.2020.11754210.1016/j.lfs.2020.117542 ↗
32. 10.1007/s00401-014-1381-010.1007/s00401-014-1381-0 ↗
33. 10.1161/STROKEAHA.115.01062010.1161/STROKEAHA.115.010620 ↗
34. 10.3389/fnmol.2020.0002810.3389/fnmol.2020.00028 ↗
35. 10.1016/S0149-7634(96)00001-210.1016/S0149-7634(96)00001-2 ↗
36. 10.1016/j.drudis.2006.10.01310.1016/j.drudis.2006.10.013 ↗
37. 10.1002/ana.2242610.1002/ana.22426 ↗
38. 10.1038/jcbfm.2012.12610.1038/jcbfm.2012.126 ↗
39. 10.1038/jcbfm.2015.4510.1038/jcbfm.2015.45 ↗
40. 10.1161/STROKEAHA.122.03694610.1161/STROKEAHA.122.036946 ↗
41. 10.5853/jos.2019.0223610.5853/jos.2019.02236 ↗
42. 10.1002/adma.20220132210.1002/adma.202201322 ↗
43. 10.2174/092986732666619030813373210.2174/0929867326666190308133732 ↗
44. 10.1056/NEJMoa090783910.1056/NEJMoa0907839 ↗
45. 10.1016/S1474-4422(14)70049-310.1016/S1474-4422(14)70049-3 ↗
46. 10.1007/s40120-019-00160-910.1007/s40120-019-00160-9 ↗
47. 10.1073/pnas.141616611110.1073/pnas.1416166111 ↗
48. Bai P. · Pharmacol. Res. Perspect. · 2022 · 1010.1002/prp2.972 ↗
49. 10.1056/NEJMoa111428710.1056/NEJMoa1114287 ↗
50. 10.2174/15680260978986964610.2174/156802609789869646 ↗
51. 10.1016/j.bcp.2023.11577210.1016/j.bcp.2023.115772 ↗
52. 10.3389/fimmu.2020.0000110.3389/fimmu.2020.00001 ↗
53. 10.3390/ijms1810213510.3390/ijms18102135 ↗
54. 10.3389/fimmu.2022.89702210.3389/fimmu.2022.897022 ↗
55. 10.1177/174749301984124210.1177/1747493019841242 ↗
56. 10.1016/j.ymthe.2021.04.02510.1016/j.ymthe.2021.04.025 ↗
57. 10.1007/s12017-023-08736-310.1007/s12017-023-08736-3 ↗
58. 10.1016/j.celrep.2018.03.01110.1016/j.celrep.2018.03.011 ↗
59. 10.1016/j.yexcr.2017.11.01510.1016/j.yexcr.2017.11.015 ↗
60. 10.1016/j.gene.2019.14427710.1016/j.gene.2019.144277 ↗
61. 10.1111/j.1471-4159.2006.04056.x10.1111/j.1471-4159.2006.04056.x ↗
62. 10.1007/s10571-018-00646-410.1007/s10571-018-00646-4 ↗
63. 10.1186/s12967-022-03779-910.1186/s12967-022-03779-9 ↗
64. 10.1093/g3journal/jkad20710.1093/g3journal/jkad207 ↗
65. 10.1155/2022/229886510.1155/2022/2298865 ↗
66. 10.1126/sciimmunol.abd128710.1126/sciimmunol.abd1287 ↗